Carmine Lanni

1.0k total citations
24 papers, 796 citations indexed

About

Carmine Lanni is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Carmine Lanni has authored 24 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Carmine Lanni's work include Asthma and respiratory diseases (6 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Synthesis of Organic Compounds (4 papers). Carmine Lanni is often cited by papers focused on Asthma and respiratory diseases (6 papers), Synthesis and Reactions of Organic Compounds (4 papers) and Synthesis of Organic Compounds (4 papers). Carmine Lanni collaborates with scholars based in United States and United Kingdom. Carmine Lanni's co-authors include Richard C. Franson, Randy L. Bell, E L Becker, Robert L. Jesse, David Eisen, Evan D. Kharasch, Dee W. Brooks, Patrick Young, E. L. Becker and James B. Summers and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Stroke and Annals of the New York Academy of Sciences.

In The Last Decade

Carmine Lanni

24 papers receiving 757 citations

Peers

Carmine Lanni

PHYSI

PHARM

OPHTH

RNMI

Giorgio Bettoni Italy

Saul Lowitt United States

Gordon Loewen United States

Takehiro Kawashiri Japan

尚三山本

Shoji Takakura Japan

Toshiyo Sonta Japan

Daniele Penzo Italy

A. Ocetkiewicz Poland

Motoyoshi Ikebuchi Japan

Giorgio Bettoni Italy

Carmine Lanni

198 ×0.8

247 ×1.2

PHYSI

121 ×0.8

PHARM

24 ×0.3

OPHTH

63 ×0.7

RNMI

Citations per year, relative to Carmine Lanni Carmine Lanni (= 1×) peers Giorgio Bettoni

Countries citing papers authored by Carmine Lanni

Since Specialization

Citations

This map shows the geographic impact of Carmine Lanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Lanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Lanni more than expected).

Fields of papers citing papers by Carmine Lanni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Lanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Lanni. The network helps show where Carmine Lanni may publish in the future.

Co-authorship network of co-authors of Carmine Lanni

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Lanni. A scholar is included among the top collaborators of Carmine Lanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Lanni. Carmine Lanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Susan S., Corine Ghosn, Zhi‐Ling Yu, et al.. (2010). Vitreous VEGF Clearance Is Increased after Vitrectomy. Investigative Ophthalmology & Visual Science. 51(4). 2135–2135. 96 indexed citations

Hasday, Jeffrey D., Susan S. Meltzer, Wendy C. Moore, et al.. (2000). Anti-inflammatory Effects of Zileuton in a Subpopulation of Allergic Asthmatics. American Journal of Respiratory and Critical Care Medicine. 161(4). 1229–1236. 49 indexed citations

Wong, Shekman, Jeffrey Drajesk, Min S. Chang, et al.. (1998). Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers. Clinical Pharmacology & Therapeutics. 63(3). 324–331. 7 indexed citations

Ahmed, Amany A.E., et al.. (1997). The pharmacokinetics of paracalcin. Clinical Pharmacology & Therapeutics. 61(2). 218. 1 indexed citations

Brooks, Clint D. W., Andrew O. Stewart, A. BASHA, et al.. (1996). ChemInform Abstract: (R)‐(+)‐N‐(3‐(5‐((4‐Fluorophenyl)methyl)‐2‐thienyl)‐1‐methyl‐2‐ propynyl)‐N‐hydroxyurea (ABT‐761), a Second‐Generation 5‐Lipoxygenase Inhibitor.. ChemInform. 27(14). 1 indexed citations

Bhatia, Pramila, Clint D. W. Brooks, Anwer Basha, et al.. (1996). 5-Lipoxygenase Inhibitors: Synthesis and Structure−Activity Relationships of a Series of 1-Aryl-2H,4H-tetrahydro-1,2,4-triazin-3-ones. Journal of Medicinal Chemistry. 39(20). 3938–3950. 24 indexed citations

Kharasch, Evan D., et al.. (1995). Clinical Sevoflurane Metabolism and Disposition. Anesthesiology. 82(6). 1369–1378.. 90 indexed citations

Brooks, Carter D., Andrew O. Stewart, Ali Basha, et al.. (1995). Preparation of (R)-(+)-N-[3-[5-[(4-Fluorophenyl)methyl]-2-thienyl]-1-methyl-2-propynyl]-N-hydroxyurea (ABT-761), a second-generation 5-lipoxygenase inhibitor.. Journal of Medicinal Chemistry. 38(24). 4768–4775. 32 indexed citations

Carter, George W., Randy L. Bell, Kennan Marsh, et al.. (1994). Stereoselective Metabolism of the 5‐Lipoxygenase Inhibitor A‐78773. Annals of the New York Academy of Sciences. 744(1). 262–273. 4 indexed citations

10.

Bell, Randy L., Jennifer B. Bouska, Patrick Young, et al.. (1993). The properties of A-69412: A small hydrophilic 5-lipoxygenase inhibitor. Inflammation Research. 38(1-2). 178–187. 9 indexed citations

11.

Bell, Randy L., Dee W. Brooks, Patrick Young, et al.. (1993). A-78773: a selective, potent 5-lipoxygenase inhibitor.. PubMed. 6(1-3). 259–64. 7 indexed citations

12.

Abraham, William M., Ashfaq Ahmed, Alejandro Cortes, et al.. (1992). The 5-lipoxygenase inhibitor zileuton blocks antigen-induced late airway responses, inflammation and airway hyperresponsiveness in allergic sheep. European Journal of Pharmacology. 217(2-3). 119–126. 43 indexed citations

13.

Bell, Randy L., Patrick Young, Daniel H. Albert, et al.. (1992). The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor. International Journal of Immunopharmacology. 14(3). 505–510. 99 indexed citations

14.

Young, Patrick, Randy L. Bell, Carmine Lanni, et al.. (1991). Inhibition of leukotriene biosynthesis in the rat peritoneal cavity. European Journal of Pharmacology. 205(3). 259–266. 26 indexed citations

15.

Frangakis, Crist, et al.. (1989). The Role of Cyclic AMP and the Dihydropyridine-Sensitive Channels on the Mechanism of Action of Milrinone (Corotrope). Journal of Cardiovascular Pharmacology. 13(6). 915–924. 18 indexed citations

16.

Lanni, Carmine & E L Becker. (1985). Inhibition of Neutrophil Phospholipase A<sub>2</sub> by <i>p</i>-Bromophenylacyl Bromide, Nordihydroguaiaretic Acid, 5,8,11,14-Eicosatetrayenoic Acid and Quercetin. International Archives of Allergy and Immunology. 76(3). 214–217. 55 indexed citations

17.

Lanni, Carmine & E. L. Becker. (1983). Release of phospholipase A2 activity from rabbit peritoneal neutrophils by f-Met-Leu-Phe.. PubMed. 113(1). 90–4. 42 indexed citations

18.

Lanni, Carmine & Richard C. Franson. (1981). Localization and partial purification of a neutral-active phospholipase A2 from BCG-induced rabbit alveolar macrophages. Biochimica et Biophysica Acta (BBA) - Enzymology. 658(1). 54–63. 26 indexed citations

19.

Franson, Richard C., David Eisen, Robert L. Jesse, & Carmine Lanni. (1980). Inhibition of highly purified mammalian phospholipases A2 by non-steroidal anti-inflammatory agents. Modulation by calcium ions. Biochemical Journal. 186(2). 633–636. 106 indexed citations

20.

Fedorko, Martha E. & Carmine Lanni. (1975). Uptake of ionic 55Fe by mouse peritoneal macrophages in vitro. Experimental Cell Research. 95(2). 385–395. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact